Related Experiment Video
Updated: Jul 29, 2026

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease
M A Monroy1, F P Ross, S L Teitelbaum
1Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Abstract:
Mucopolysaccharidosis type VII (MPS VII) is a heritable lysosomal storage disease caused by a deficiency in beta-glucuronidase (GUSB) activity, leading to progressive accumulation of undegraded glycosaminoglycans in many tissues. Clinical features include growth and mental retardation, hearing and visual defects, shortened lifespan, and skeletal deformities. A murine model of MPS VII has been described that shares many of the manifestations of the human disease, including the skeletal dysplasia. In this study we describe abnormalities in the cellular morphology and function of osteoclasts and a localized defect in bone formation rate in the MPS VII mouse. Ultrastructural analysis revealed that MPS VII osteoclasts fail to form ruffled border membranes and many appeared to be detached from the bone surface. Following bone marrow transplantation, osteoclasts derived from wild-type donors showed normal morphology and were closely associated with the bone surface in MPS VII recipients. In vitro bone resorption assays demonstrated that MPS VII osteoclasts formed significantly smaller and fewer pits than those formed by osteoclasts derived from normal mice of the same strain. Although osteoclast morphology and function appeared to be abnormal in the MPS VII mouse, interleukin-1 (IL-1)-induced osteoclastogenesis in vivo was not affected. In addition to the osteoclast defects, MPS VII mice demonstrated a slower rate of bone matrix deposition in the epiphysis by in vivo calcein labeling experiments. These data suggest that abnormal morphology and function of MPS VII osteoclasts, combined with deficient matrix deposition, may contribute to the skeletal defects observed in this lysosomal storage disease.
Insights
Mucopolysaccharidosis type VII (MPS VII), a lysosomal storage disease, causes skeletal deformities due to impaired beta-glucuronidase activity. This study reveals abnormal osteoclast function and reduced bone formation in MPS VII mice, contributing to skeletal defects.
Area of Science:
- Biochemistry
- Genetics
- Skeletal Biology
Background:
- Mucopolysaccharidosis type VII (MPS VII) is a genetic lysosomal storage disorder resulting from beta-glucuronidase (GUSB) deficiency.
- This deficiency leads to the accumulation of glycosaminoglycans, causing widespread tissue damage and skeletal deformities.
- A murine model of MPS VII exhibits similar skeletal dysplasia to human patients.
Purpose of the Study:
- To investigate the cellular and functional abnormalities of osteoclasts in MPS VII mice.
- To determine the impact of GUSB deficiency on bone formation rates.
- To elucidate the mechanisms underlying skeletal defects in MPS VII.
Main Methods:
- Ultrastructural analysis of osteoclast morphology and bone surface interaction.
- In vitro bone resorption assays using MPS VII and wild-type osteoclasts.
- Bone marrow transplantation experiments to assess donor osteoclast function in MPS VII recipients.
- In vivo calcein labeling to measure bone formation rates.
Main Results:
- MPS VII osteoclasts exhibited abnormal morphology, including a lack of ruffled borders and detachment from bone.
- Bone marrow transplantation normalized osteoclast morphology and function in MPS VII recipients.
- MPS VII osteoclasts showed significantly reduced in vitro bone resorption capacity.
- MPS VII mice displayed a slower rate of bone matrix deposition in the epiphysis.
Conclusions:
- Abnormal osteoclast morphology and function, coupled with impaired bone matrix deposition, contribute to the skeletal dysplasia observed in MPS VII.
- GUSB deficiency directly impacts osteoclast activity and bone formation, highlighting a critical role in skeletal integrity.
- The MPS VII mouse model provides valuable insights into the pathogenesis of skeletal defects in this lysosomal storage disease.
Related Concept Videos
Bone Remodeling
Lysosomal Hydrolases
Osteoclasts in Bone Remodeling

